p53 and cancer therapy: a double-edged sword
AUTOR(ES)
McGill, Gaël
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=408427Documentos Relacionados
- Myocardial reperfusion: a double-edged sword?
- The double-edged sword of COX-2 selective NSAIDs
- Dealing with diabetes and pregnancy following bariatric surgery: a double-edged sword?
- Mac the knife? Macrophages– the double-edged sword of hepatic fibrosis
- Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword